|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 145.84 USD | -0.77% |
|
+0.76% | +1.59% |
| 08-07 | US wellness shot brand Dose explores sale, sources say | RE |
| 08-05 | Deals of the day-Mergers and acquisitions | RE |
Company Valuation: Procter & Gamble Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 344,995 | 357,647 | 389,234 | 373,532 | 341,466 | 341,622 | - | - |
| Change | - | 3.67% | 8.83% | -4.03% | -8.58% | 0.05% | - | - |
| Enterprise Value (EV) 1 | 369,274 | 384,008 | 412,212 | 398,484 | 365,662 | 365,960 | 364,889 | 363,507 |
| Change | - | 3.99% | 7.34% | -3.33% | -8.24% | 0.08% | -0.29% | -0.38% |
| P/E | 24.7x | 25.7x | 27.4x | 24.5x | 22.2x | 21.3x | 19.9x | 19.1x |
| PBR | 7.35x | 7.66x | 8.06x | 7.48x | 6.54x | 6.22x | 5.97x | 5.71x |
| PEG | - | 16.59x | 13.47x | 3.01x | 13.14x | 5.19x | 2.83x | 4.27x |
| Capitalization / Revenue | 4.3x | 4.36x | 4.63x | 4.43x | 3.92x | 3.85x | 3.73x | 3.61x |
| EV / Revenue | 4.61x | 4.68x | 4.91x | 4.73x | 4.2x | 4.12x | 3.99x | 3.85x |
| EV / EBITDA | 17.9x | 18.4x | 18x | 17.1x | 15.5x | 15x | 14.3x | 13.5x |
| EV / EBIT | 20.7x | 21.2x | 20.6x | 19.5x | 17.8x | 17.4x | 16.5x | 15.7x |
| EV / FCF | 27.2x | 27.9x | 24.9x | 27.3x | 24.1x | 23x | 21.9x | 20.7x |
| FCF Yield | 3.67% | 3.59% | 4.01% | 3.67% | 4.14% | 4.35% | 4.57% | 4.83% |
| Dividend per Share 2 | 3.523 | 3.681 | 3.829 | 4.076 | 4.259 | 4.432 | 4.611 | 4.838 |
| Rate of return | 2.45% | 2.43% | 2.32% | 2.56% | 2.9% | 3.02% | 3.14% | 3.29% |
| EPS 2 | 5.81 | 5.9 | 6.02 | 6.51 | 6.62 | 6.892 | 7.376 | 7.705 |
| Distribution rate | 60.6% | 62.4% | 63.6% | 62.6% | 64.3% | 64.3% | 62.5% | 62.8% |
| Net sales 1 | 80,187 | 82,006 | 84,039 | 84,284 | 87,032 | 88,748 | 91,484 | 94,533 |
| EBITDA 1 | 20,620 | 20,848 | 22,884 | 23,303 | 23,657 | 24,350 | 25,606 | 26,834 |
| EBIT 1 | 17,813 | 18,134 | 19,988 | 20,456 | 20,497 | 20,998 | 22,060 | 23,137 |
| Net income 1 | 14,742 | 14,653 | 14,879 | 15,974 | 16,046 | 16,585 | 17,578 | 18,230 |
| Net Debt 1 | 24,279 | 26,361 | 22,978 | 24,952 | 24,196 | 24,338 | 23,267 | 21,886 |
| Reference price 2 | 143.79 | 151.74 | 164.92 | 159.32 | 146.64 | 146.97 | 146.97 | 146.97 |
| Nbr of stocks (in thousands) | 2,399,297 | 2,356,969 | 2,360,135 | 2,344,542 | 2,328,599 | 2,324,433 | - | - |
| Announcement Date | 29/7/22 | 28/7/23 | 30/7/24 | 29/7/25 | 29/7/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.33x | 4.12x | 15.03x | 3.02% | 342B | |
| 18.11x | 2.75x | 12.14x | 3.48% | 136B | |
| 25.29x | 3.78x | 15.88x | 2.28% | 74.14B | |
| 43.13x | 6.95x | 30.15x | 2.14% | 51.29B | |
| 20.24x | 2.77x | 11.49x | 4.47% | 36.83B | |
| 82.68x | 2.44x | 14.73x | 1.65% | 30.93B | |
| 21.69x | 1.41x | 8.98x | 1.2% | 20.59B | |
| 23.48x | 1.72x | 10.98x | 2.17% | 20.54B | |
| 16.26x | 1.56x | 8.89x | 3.25% | 20.09B | |
| 45.75x | 6.62x | 31.62x | 1.59% | 11.57B | |
| Average | 31.80x | 3.41x | 15.99x | 2.52% | 74.4B | |
| Weighted average by Cap. | 25.44x | 3.72x | 15.25x | 2.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PG Stock
- Valuation Procter & Gamble Company
Select your edition
All financial news and data tailored to specific country editions
